Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy

We evaluated the long-term prognosis of the eyes of patients with polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). In total, 60 eyes of 57 patients diagnosed with PCV and treated with PDT were reviewed retrospectively in real-world settings. The best-corrected visual...

Full description

Bibliographic Details
Main Authors: Yukinori Sakaeda, Aki Kato, Soichiro Kuwayama, Shuichiro Hirahara, Norihiro Suzuki, Yuichiro Ogura, Yoko Nakazawa, Tsutomu Yasukawa
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/14/4707
_version_ 1797588871293173760
author Yukinori Sakaeda
Aki Kato
Soichiro Kuwayama
Shuichiro Hirahara
Norihiro Suzuki
Yuichiro Ogura
Yoko Nakazawa
Tsutomu Yasukawa
author_facet Yukinori Sakaeda
Aki Kato
Soichiro Kuwayama
Shuichiro Hirahara
Norihiro Suzuki
Yuichiro Ogura
Yoko Nakazawa
Tsutomu Yasukawa
author_sort Yukinori Sakaeda
collection DOAJ
description We evaluated the long-term prognosis of the eyes of patients with polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). In total, 60 eyes of 57 patients diagnosed with PCV and treated with PDT were reviewed retrospectively in real-world settings. The best-corrected visual acuity (BCVA), central retinal thickness (CRT), anatomical findings (vision-threatening findings), and treatment history were assessed. In total, 38 eyes underwent PDT as the initial treatment (initial PDT group) and 22 eyes underwent PDT as a rescue treatment (rescue PDT group). In the initial PDT group, 11 eyes (29%) did not require additional therapy throughout the observation period and maintained good BCVA. A total of 27 eyes (71%) underwent additional treatments and the mean BCVA was only stabilized for 2 years; thereafter, decreased vision occurred even with additional treatments. In the rescue PDT group, 22 eyes (95%) required additional treatment. Hard exudate, serous pigment epithelial detachment, and the total vision-threatening score were related to worse BCVA. Initial PDT may be effective in about 30% of cases with preservation of good vision and no need for additional treatment. However, patients with received rescue PDT needed additional treatment in most cases and the vision decreased in many cases.
first_indexed 2024-03-11T00:58:11Z
format Article
id doaj.art-e8a32fabc0484d9d8830c96610b69c90
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T00:58:11Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-e8a32fabc0484d9d8830c96610b69c902023-11-18T19:52:49ZengMDPI AGJournal of Clinical Medicine2077-03832023-07-011214470710.3390/jcm12144707Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic TherapyYukinori Sakaeda0Aki Kato1Soichiro Kuwayama2Shuichiro Hirahara3Norihiro Suzuki4Yuichiro Ogura5Yoko Nakazawa6Tsutomu Yasukawa7Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanDepartment of Ophthalmology, Nagoya City University, West Medical Center, 1-1-1 Hirate-cho, Kita-ku, Nagoya 462-8508, JapanDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JapanWe evaluated the long-term prognosis of the eyes of patients with polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). In total, 60 eyes of 57 patients diagnosed with PCV and treated with PDT were reviewed retrospectively in real-world settings. The best-corrected visual acuity (BCVA), central retinal thickness (CRT), anatomical findings (vision-threatening findings), and treatment history were assessed. In total, 38 eyes underwent PDT as the initial treatment (initial PDT group) and 22 eyes underwent PDT as a rescue treatment (rescue PDT group). In the initial PDT group, 11 eyes (29%) did not require additional therapy throughout the observation period and maintained good BCVA. A total of 27 eyes (71%) underwent additional treatments and the mean BCVA was only stabilized for 2 years; thereafter, decreased vision occurred even with additional treatments. In the rescue PDT group, 22 eyes (95%) required additional treatment. Hard exudate, serous pigment epithelial detachment, and the total vision-threatening score were related to worse BCVA. Initial PDT may be effective in about 30% of cases with preservation of good vision and no need for additional treatment. However, patients with received rescue PDT needed additional treatment in most cases and the vision decreased in many cases.https://www.mdpi.com/2077-0383/12/14/4707age-related macular degenerationanti-vascular endothelial growth factor therapyphotodynamic therapypolypoidal choroidal vasculopathy
spellingShingle Yukinori Sakaeda
Aki Kato
Soichiro Kuwayama
Shuichiro Hirahara
Norihiro Suzuki
Yuichiro Ogura
Yoko Nakazawa
Tsutomu Yasukawa
Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
Journal of Clinical Medicine
age-related macular degeneration
anti-vascular endothelial growth factor therapy
photodynamic therapy
polypoidal choroidal vasculopathy
title Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
title_full Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
title_fullStr Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
title_full_unstemmed Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
title_short Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
title_sort long term prognosis of patients with polypoidal choroidal vasculopathy treated with photodynamic therapy
topic age-related macular degeneration
anti-vascular endothelial growth factor therapy
photodynamic therapy
polypoidal choroidal vasculopathy
url https://www.mdpi.com/2077-0383/12/14/4707
work_keys_str_mv AT yukinorisakaeda longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT akikato longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT soichirokuwayama longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT shuichirohirahara longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT norihirosuzuki longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT yuichiroogura longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT yokonakazawa longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy
AT tsutomuyasukawa longtermprognosisofpatientswithpolypoidalchoroidalvasculopathytreatedwithphotodynamictherapy